most effective glp-1 for obesity treatment 2025 receptor agonists show anti-cancer benefits beyond weight loss GLP-1 Impact: How GLP-1s Are

Importantly, a substantial number of patients had multiple reasons noted for stopping (21%), underscoring the complexity of real-world medication use and the challenges patients face when using these therapies

Genetics also play a significant role in determining where stubborn fat persists

While these medications can offer powerful health benefits, theyre not without side effects

What happens after the first month We continue what works and adjust what does not

SURPASS-2 showed tirzepatide 15mg superior to semaglutide 1mg in a head-to-head T2D trial

Adequate protein intake may help to support muscle retention and may help with satiety (fullness) after medication stops